Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Imv (Us) (IMVIF)
:IMVIF
Holding IMVIF?
Track your performance easily
IMVIF Stock Chart & Stats
Day’s RangeN/A
52-Week Range― - ―
Previous CloseN/A
Volume593.00
Average Volume (3M)190.00
Market Cap
$9.07M
Enterprise ValueN/A
Total Cash (Recent Filing)$7.78M
Total Debt (Recent Filing)$5.78M
Price to Earnings (P/E)―
Beta-28.68
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding11,711,637
10 Day Avg. Volume59
30 Day Avg. Volume190
Standard Deviation25.71
R-Squared0.00368
Alpha2.84
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
3.49% Other Institutional Investors
96.51% Public Companies and
Individual Investors
IMVIF FAQ
What was Imv (Us)’s price range in the past 12 months?
Currently, no data Available
What is Imv (Us)’s market cap?
Imv (Us)’s market cap is $9.07M.
When is Imv (Us)’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Imv (Us)’s earnings last quarter?
Currently, no data Available
Is Imv (Us) overvalued?
According to Wall Street analysts Imv (Us)’s price is currently Overvalued.
Does Imv (Us) pay dividends?
Imv (Us) does not currently pay dividends.
What is Imv (Us)’s EPS estimate?
Imv (Us)’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Imv (Us) have?
Imv (Us) has 11,711,637 shares outstanding.
What happened to Imv (Us)’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Imv (Us)?
Currently, no hedge funds are holding shares in IMVIF
---
Company Description
Imv (Us)
IMV, Inc. is a clinical-stage biopharmaceutical company pioneering a new class of immunotherapy in Oncology. Its proprietary drug delivery platform (DPX) enables the programming of immune cells in vivo. The firm's candidate, DPX-Survivac, is a T cell-activating immunotherapy combining DPX with a specific tumor target: Survivin. DPX-Survivac is in clinical evaluation as a monotherapy in advanced ovarian cancer and in combination with Merck's Keytruda across multiple cancer indications. The company was founded by Warwick Kimmins and Brian E. Lowe on March 28, 2000 and is headquartered in Dartmouth, Canada.
---
---